Transphorm, Inc.
TGAN
$4.75
-$0.05-1.04%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.67M | 5.01M | 5.88M | 3.19M | 4.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.67M | 5.01M | 5.88M | 3.19M | 4.49M |
| Cost of Revenue | 4.60M | 3.84M | 3.80M | 3.02M | 7.16M |
| Gross Profit | 75.00K | 1.17M | 2.09M | 175.00K | -2.67M |
| SG&A Expenses | 5.95M | 4.65M | 6.00M | 5.51M | 4.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.38M | 11.51M | 12.66M | 11.54M | 14.39M |
| Operating Income | -8.71M | -6.50M | -6.78M | -8.34M | -9.90M |
| Income Before Tax | -10.00M | -7.13M | -7.45M | -8.79M | -10.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.00M | -7.13M | -7.45M | -8.79M | -10.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.00M | -7.13M | -7.45M | -8.79M | -10.46M |
| EBIT | -8.71M | -6.50M | -6.78M | -8.34M | -9.90M |
| EBITDA | -8.41M | -6.16M | -6.51M | -8.09M | -9.64M |
| EPS Basic | -0.20 | -0.12 | -0.22 | -0.15 | -0.18 |
| Normalized Basic EPS | -0.10 | -0.07 | -0.08 | -0.10 | -0.12 |
| EPS Diluted | -0.20 | -0.12 | -0.22 | -0.15 | -0.18 |
| Normalized Diluted EPS | -0.10 | -0.07 | -0.08 | -0.10 | -0.12 |
| Average Basic Shares Outstanding | 62.18M | 61.14M | 59.26M | 57.14M | 56.74M |
| Average Diluted Shares Outstanding | 62.18M | 61.14M | 59.26M | 57.14M | 56.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
